A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Corneal Edema After Cataract Surgery

In brief

The purpose of this study is to assess the safety and efficacy of K-321 in subjects after cataract surgery

Key facts

Study ID
NCT05528172
Run by
Kowa Research Institute, Inc.
People needed
330
Starts
2022-08-04
Expected to finish
2023-06-22
Last updated by the study team
2026-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.